HB 374

  • Delaware House Bill
  • 149th General Assembly (2017-2018)
  • Introduced in House May 03, 2018
  • Passed House May 01, 2018
  • Passed Senate Jun 20, 2018
  • Signed by Governor Aug 28, 2018

An Act To Amend Title 16 Of The Delaware Code Relating To The Medical Marijuana Act.

Abstract

This bill adds glaucoma, chronic debilitating migraines, pediatric autism spectrum disorder, pediatric sensory processing disorder to the list of debilitating medical conditions which may qualify a person, upon certification by a physician, to be eligible for the use of medical marijuana in accordance with the terms of the Delaware Medical Marijuana Act.

Bill Sponsors (24)

Votes


Jun 20, 2018

May 01, 2018

Actions


Aug 28, 2018

Office of the Governor

Signed by Governor

Jun 20, 2018

Senate

Passed By Senate. Votes: 19 YES 2 ABSENT

Jun 06, 2018

Senate

Reported Out of Committee (Health, Children & Social Services) in Senate with 5 On Its Merits

  • Committee-Passage
Health, Children & Social Services

May 03, 2018

Senate

Assigned to Health, Children & Social Services Committee in Senate

  • Introduction
  • Referral-Committee
Health, Children & Social Services

May 01, 2018

House

Passed By House. Votes: 41 YES

House

Amendment HA 1 to HB 374 - Passed In House by Voice Vote

Apr 25, 2018

House

Reported Out of Committee (Health & Human Development) in House with 9 On Its Merits

  • Committee-Passage
Health & Human Development

House

Amendment HA 1 to HB 374 - Introduced and Placed With Bill

Apr 17, 2018

House

Introduced and Assigned to Health & Human Development Committee in House

  • Introduction
  • Referral-Committee
Health & Human Development

Bill Text

Bill Text Versions Format
Bill Text HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Delaware General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.